Sutro Biopharma Inc. will host a virtual Research & Development Day on November 12, 2025, where the company will highlight details of its platform innovation and next-generation antibody drug conjugate pipeline.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sutro Biopharma Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9568450-en) on November 05, 2025, and is solely responsible for the information contained therein.
Comments